TRADING UPDATES: Made Tech to beat consensus; Time Finance profit up
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
Price | 3.30p on 09-07-2025 | at 07:01:34
---|---|
Change | 0.10p 3.13% |
Buy | 3.40p |
Sell | 3.20p |
Buy / Sell SAV Shares |
Last Trade: | Sell 2,000.00 at 3.20p |
Day's Volume: | 5,012 |
Last Close: | 3.20p |
Open: | 3.30p |
ISIN: | GB00B647W791 |
Day's Range | 3.30p - 3.30p |
52wk Range: | 3.20p - 5.70p |
Market Capitalisation: | £76m |
VWAP: | 3.272115p |
Shares in Issue: | 2,309m |
Sector: Industrial Metals
Listed In: FTSE AIM All-Share,
Savannah Resources (SAV) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 2,000 | 3.20p | Ordinary |
08:01:33 - 09-Jul-25 |
Buy* | 3,012 | 3.32p | Ordinary |
08:00:30 - 09-Jul-25 |
Unknown* | 1,000,000 | 3.25p | Ordinary |
16:36:30 - 08-Jul-25 |
Sell* | 256,000 | 3.20p | Uncrossing Trade |
16:35:26 - 08-Jul-25 |
Buy* | 5,935 | 3.32p | Ordinary |
16:16:20 - 08-Jul-25 |
Buy* | 8,676 | 3.32p | Ordinary |
16:12:48 - 08-Jul-25 |
Buy* | 400,000 | 3.33p | Ordinary |
15:55:28 - 08-Jul-25 |
Buy* | 1,000 | 3.35p | Ordinary |
15:51:03 - 08-Jul-25 |
Buy* | 74,716 | 3.33p | Ordinary |
15:26:13 - 08-Jul-25 |
Buy* | 294 | 3.40p | Ordinary |
15:14:51 - 08-Jul-25 |
Savannah Resources (SAV) Regulatory News |
||
Date | Source | Headline |
---|---|---|
2nd Jul 2025 7:00 am | RNS | Retail Offer increases Fundraise to £4.8 million |
27th Jun 2025 7:20 am | RNS | Result of Accelerated Bookbuild and Subscription |
26th Jun 2025 5:00 pm | RNS | RetailBook Offer |
26th Jun 2025 4:51 pm | RNS | Proposed Fundraise |
18th Jun 2025 1:27 pm | RNS | PDMR Notification |
16th Jun 2025 7:00 am | RNS | Savannah Announces Advisory Committee |
12th Jun 2025 7:00 am | RNS | Barroso Lithium Project - Update |
10th Jun 2025 12:04 pm | RNS | Result of AGM |
10th Jun 2025 7:00 am | RNS | AGM Statement |
29th May 2025 7:02 am | RNS | More encouraging results in third batch of assays |